Related Experiment Video
Updated: May 23, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Geographic variation in procedure selection and hospital mortality in mitral valve surgery
Christina Vassileva1, Joshua DiGennaro, Theresa Boley
1Division of Cardiothoracic Surgery, Southern Illinois University School of Medicine, 701 N. First St., Room D318, Springfield, IL 62794-9638, USA. cvassileva@siumed.edu
Background And Aim Of The Study:
There is paucity of data relating to the geographic variation in mitral valve (MV) repair trends and outcomes of patients undergoing MV surgery.
Methods:
Using the 2005-2008 Nationwide Inpatient Sample (NIS) Database, the four geographic regions of the US (Northeast, Midwest, South, and West) were compared with respect to baseline characteristics, mitral procedure selection, and hospital mortality of patients undergoing either MV repair (ICD-9CM code 35.12) or replacement (ICD-9-CM codes 35.23 and 35.24).
Results:
Patient age was similar across regions. The Midwest had the highest proportion of whites, while patients in the South were the least affluent. The Northeast had the highest proportion of patients presenting non-electively. The West and Midwest had more women and patients with private insurance compared to the South, but the proportion of patients on Medicaid was similar across all regions. The Northeast and the South had a higher Charlson Comorbidity Index compared to the West. The overall repair rate was 47%; the Midwest had the highest rate (50%), and the South the lowest (42%) (p = NS). Following adjustment for baseline characteristics, hospital mortality was similar among regions for patients undergoing MV replacement. For the subset undergoing MV repair, hospital mortality was more than 2.5-fold higher in the South than in the Northeast (OR = 2.88, 95% CI 1.45-5.71).
Conclusion:
MV repair is utilized in less than half of all mitral procedures nationwide. Repair rates and hospital mortality are comparable across all four regions in the US. Hospital mortality for isolated MV surgery is low. The higher adjusted mortality for patients undergoing MV repair in the South identifies an important area for future improvement in the care of patients with valvular heart disease.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

